KURSSIT JA MARKKINAT / UUTISET

Form 8.3 - [Allergan plc]

18.10.2019 klo 17:01 Form 8.3 - [Allergan plc]

                FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) State Street Global Advisors & Affiliates Company dealt in Allergan plc Class of relevant security to which
the dealings being disclosed relate (Note 2) US$0.0001 ordinary shares Date of dealing 17th October 2019    

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

  Long Short   Number (%) Number (%) (1) Relevant securities 15,439,087 4.70528%     (2) Derivatives (other than options) N/A       (3) Options and agreements to
purchase/sell N/A       Total 15,439,087 4.70528%    

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short   Number (%) Number (%) (1) Relevant securities N/A       (2) Derivatives (other than options) N/A       (3) Options and agreements to purchase/sell N/A       Total N/A      

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit (Note 5) Purchase 235 171.66 Purchase 1,300 172.84 Purchase 40 172.50 Purchase 11,820 172.50 Purchase 184 172.50 Sale 6,648 172.50 Sale 15,563 172.50 Sale 1,317 172.50 Sale 24 172.50

 (b) Derivatives transactions (other than options transactions)

Product name,
e.g. CFD Nature of transaction

(Note 6) Number of relevant securities

(Note 7) Price per unit

(Note 5) N/A      

                                                                                                                                                     
(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,
e.g. call option Writing, selling,
purchasing
 varying etc. Number of
securities to which
the option relates
(Note 7) Exercise
price Type, e.g.
American,
European etc. Expiry
date Option money
paid/received
per unit (Note 5) N/A            

(ii) Exercising

Product name,
e.g. call option Number of securities Exercise price per
unit (Note 5) N/A    

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction
(Note 8) Details Price per unit
(if applicable) (Note 5) N/A    

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. N/A


Is a Supplemental Form 8 attached? (Note 9) NO


Date of disclosure 18th October 2019 Contact name Lionel Colaco Telephone number                                                             020 33956098 If a connected EFM, name of offeree/offeror with which connected N/A If a connected EFM, state nature of connection (Note 10) N/A

GlobeNewswire